{
  "ptid_time": "068_S_4134_2011-10-31",
  "img_path": "/data/qiuhui/data/adni/images/068_S_4134/2011-10-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 19,778 mm³, 11.5% below the reference mean. With a Z-score of -0.29 (38.7th percentile), this represents normal volume ; hippocampal volume measures 8,226 mm³, 7.0% above the reference mean. With a Z-score of 0.79 (78.5th percentile), this represents normal volume ; whole brain volume measures 1,076,900 mm³, 4.6% above the reference mean. With a Z-score of 0.58 (71.8th percentile), this represents normal volume ; entorhinal cortex volume measures 3,153 mm³, 19.0% below the reference mean. With a Z-score of -1.47 (7.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 15,159 mm³, 16.8% below the reference mean. With a Z-score of -1.89 (3.0th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 19,220 mm³, 6.3% below the reference mean. With a Z-score of -0.56 (28.7th percentile), this represents normal volume . ",
  "text_data": "Age is 68.8 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Smoking; Major Surgical Procedures. MMSE: 30.0. MoCA: 26.0. Logical Memory: 10.0. Laboratory findings: Monocytes: 0.63 (significant elevated); Monocytes: 10.30 (significant elevated); Calcium (EDTA): 11.10 (profound elevated); Phosphorus: 2.60 (significant reduced). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.58 SUVR (profound elevated); Amyloid beta: 836.80 pg/mL (normal ); Total tau: 278.50 pg/mL (normal ); Phosphorylated tau: 31.45 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild to moderate atrophy in the entorhinal cortex and fusiform gyrus, which are regions vulnerable to Alzheimer's pathology. However, hippocampal and whole brain volumes are normal, and CSF biomarkers (Aβ normal, T-tau normal, P-tau mildly elevated) do not strongly support Alzheimer’s disease despite elevated AV45 (amyloid PET). Cognitive scores (MMSE 30, MoCA 26) are borderline for MCI but not dementia.  \n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (due to conflicting biomarker and imaging findings—amyloid PET suggests amyloid deposition, but CSF and cognitive scores are not fully consistent with AD progression).",
  "timestamp": "2025-07-26T08:59:44.124904"
}